ConductScience.org, home

Paper6744286

Reduced cardiotoxicity and nephrotoxicity with preservation of antitumor activity of doxorubicin entrapped in stable liposomes in the LOU/M Wsl rat.

van Hoesel QG and 8 others. Cancer Res, 1984. Cited by 96 papers, by iCite.

Cite this record

ConductScience Library. Reduced cardiotoxicity and nephrotoxicity with preservation of antitumor activity of doxorubicin entrapped in stable liposomes in the LOU/M Wsl rat. Papers, record 6744286. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6744286

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Reduced cardiotoxicity and nephrotoxicity with preservation of antitumor activity of doxorubicin entrapped in stable liposomes in the LOU/M Wsl rat.
PubMed
Journal
Cancer Res
PubMed
Year
1984
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
96
iCite
Relative citation ratio, by iCite
4.31
iCite
Revised in PubMed
2013-11-21
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1van Hoesel QGQ G
2Steerenberg PAP A
3Crommelin DJD J
4van Dijk AA
5van Oort WW
6Klein SS
7Douze JMJ M
8de Wildt DJD J
9Hillen FCF C

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DoxorubicinMajor topic
HeartMajor topic
KidneyMajor topic
LiposomesMajor topic
LymphomaMajor topic
Animals
Dose-Response Relationship, Drug
Myocardium
Rats
Rats, Inbred Strains

Source PubMed

Download CSV of topics

Cited by23

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 96 citations.

PMIDTitleJournalYearIn PapersSource
41252081TLD-1, a Novel Liposomal Doxorubicin, in Patients with Solid Tumors: Comparative Pharmacokinetics and Final Results of a Multicenter Phase 1 Study (SAKK 65/16).Clin Pharmacokinet2026https://conductscience.org/library/papers/41252081PubMed
39885941Thirty years from FDA approval of pegylated liposomal doxorubicin (Doxil/Caelyx): an updated analysis and future perspective.BMJ Oncol2025https://conductscience.org/library/papers/39885941PubMed
34219194Doxorubicin and doxorubicin-loaded nanoliposome induce senescence by enhancing oxidative stress, hepatotoxicity, and in vivo genotoxicity in male Wistar rats.Naunyn Schmiedebergs Arch Pharmacol2021https://conductscience.org/library/papers/34219194PubMed
24310494Nanotechnology and drug delivery: an update in oncology.Pharmaceutics2011https://conductscience.org/library/papers/24310494PubMed
24277284Stability of liposomes on storage: freeze dried, frozen or as an aqueous dispersion.Pharm Res1984https://conductscience.org/library/papers/24277284PubMed
22426964Stability influences the biodistribution, toxicity, and anti-tumor activity of doxorubicin encapsulated in PEG-PE micelles in mice.Pharm Res2012https://conductscience.org/library/papers/22426964PubMed
20925429Copper-doxorubicin as a nanoparticle cargo retains efficacy with minimal toxicity.Mol Pharm2010https://conductscience.org/library/papers/20925429PubMed
11718259High concentration of Daunorubicin and Daunorubicinol in human malignant astrocytomas after systemic administration of liposomal Daunorubicin.J Neurooncol2001https://conductscience.org/library/papers/11718259PubMed
8462124Doxorubicin and doxorubicinol pharmacokinetics and tissue concentrations following bolus injection and continuous infusion of doxorubicin in the rabbit.Cancer Chemother Pharmacol1993https://conductscience.org/library/papers/8462124PubMed
8269584Identification of vesicle properties that enhance the antitumour activity of liposomal vincristine against murine L1210 leukemia.Cancer Chemother Pharmacol1993https://conductscience.org/library/papers/8269584PubMed
8200855Improvement of therapeutic effect by using Fab' fragment in the treatment of carcinoembryonic antigen-positive human solid tumors with adriamycin-entrapped immunoliposomes.Jpn J Cancer Res1994https://conductscience.org/library/papers/8200855PubMed
7767956A two-step targeting approach for delivery of doxorubicin-loaded liposomes to tumour cells in vivo.Cancer Chemother Pharmacol1995https://conductscience.org/library/papers/7767956PubMed
7642689Doxorubicin-heparin complex: reduction of cardiotoxicity of doxorubicin.J Cancer Res Clin Oncol1995https://conductscience.org/library/papers/7642689PubMed
7506649Liposomes as carriers of cancer chemotherapy. Current status and future prospects.Drugs1993https://conductscience.org/library/papers/7506649PubMed
3520474Anthracycline antitumour agents. A review of physicochemical, analytical and stability properties.Pharm Weekbl Sci1986https://conductscience.org/library/papers/3520474PubMed
3413128Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors.Proc Natl Acad Sci U S A1988https://conductscience.org/library/papers/3413128PubMed
3370737Liposomes as drug carrier system for cis-diamminedichloroplatinum (II). II. Antitumor activity in vivo, induction of drug resistance, nephrotoxicity and Pt distribution.Cancer Chemother Pharmacol1988https://conductscience.org/library/papers/3370737PubMed
3042244Clinical pharmacokinetics of doxorubicin.Clin Pharmacokinet1988https://conductscience.org/library/papers/3042244PubMed
2965295Liposomes in chemo- and immunotherapy of cancer.Lipids1987https://conductscience.org/library/papers/2965295PubMed
2791187A comparative study on the antitumor effect, cardiotoxicity and nephrotoxicity of doxorubicin given as a bolus, continuous infusion or entrapped in liposomes in the Lou/M Wsl rat.Cancer Chemother Pharmacol1989https://conductscience.org/library/papers/2791187PubMed

See all 23 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6744286

GET https://conductscience.org/api/papers/v1/6744286/cited_by?page=2